Indogulf Cropsciences Ltd Q2 FY2026 Concall Summary

Key Takeaways

• Weather wiped out the peak quarter: Revenue grew only 7% YoY in Q2, the seasonally strongest quarter, as unseasonal September floods across South India, Odisha and Punjab left farmers with no spraying window. H1 still grew 20% YoY.
• Branded B2C held the line: Key insecticide and herbicide brands, plus the AGPL (Mascot Giraffe) subsidiary, drove whatever growth there was, while exports stayed challenged by Ethiopia, Red Sea and conflict-zone disruptions.
• The 30-35% full-year guide is now at risk: Management called that target "challenging" after the Q2 miss and declined to give a revised range, though it insists the company will still be "one of the effective and promising performers" among peers.
• Biologicals and nutrients are the margin story, but the timeline is soft: The segment was hit by rain and a policy gap that has since been resolved; management is "very hopeful" of a Q3/Q4 rebound that lifts EBITDA and PAT, but refused to put a number on the 2-3 year revenue mix.
• What to watch next quarter: Whether the promised Rabi-season rebound actually materialises, the pace of biologicals revenue conversion now that the regulatory framework is in place, and any revised full-year growth signal.

The Q2 Weather Shock

• A force majeure on spraying: Continuous rain through August, September and even October, including cyclones, left no gap for farmers to apply crop protection products. Even typically dry states like Rajasthan saw heavy flooding, something management says no one in the industry anticipated.
• Seasonal concentration amplified the damage: Q2 and Q4 are the company's best-performing quarters because the branded B2C business is concentrated in those spraying windows; Q1 and Q3 are harvesting months with structurally lower margins. The Q2 miss therefore hits both revenue and the full-year profit trajectory.
• H1 still grew 20% YoY: The first quarter carried enough momentum to keep the half-year figure respectable, but the Q2 shortfall means the second half must over-deliver to close the gap.

Sanjay Aggarwal: "We were never expecting, no one in the industry was expecting so much of rain, and so much of flooding. Even the state like Rajasthan, where the water is most of the time scarce, there were heavy rains in most of the areas."

The B2C Engine & AGPL

• Branded portfolio proved resilient: Orion Gold and other key insecticide and herbicide brands held up through the disruption, peaking in July and August before the floods hit hardest. Revenue growth in the quarter was driven by the branded B2C business.
• AGPL is now the designated growth driver: The Abhiprakash Globus subsidiary (Mascot Giraffe brand) deepened reach to underserved farmers and saw its Q2 EBITDA margin rise to high single digits on improved operating leverage. Management called it "the most strategic growth driver for Indogulf as a group."
• 12 new products launched in H1: Spanning crop protection, plant nutrients and biologicals, these launches supported product mix and margin quality. New launches over the last three years contributed 3% to Q2 revenue. No further launches are planned for H2; 4-5 more are planned for next year.

Sanjay Aggarwal: "That will be the most strategic growth driver for Indogulf as a company, as a group, as a whole together and that will improve our brand business."

Biologicals & Nutrients: The Margin Bet

• A double hit in Q2: The segment was impacted both by rain and by a government policy change that temporarily excluded some biologicals from the fertilizer control order. That framework has now been developed, and Indogulf is one of the few companies whose entire product range sits within it.
• Marketing push underway: Schemes like Gatbandhan and Bhagya Chakra have been launched specifically for biologicals and nutrients, and management is "very hopeful" of a Q3 and Q4 rebound that improves both absolute contribution and percentage mix.
• Europe as a medium-term outlet: The company already has bio-fertilizers, bio-stimulants and a nutrients portfolio positioned for European markets, where integrated farming solutions are in demand. Ten products have been quality-certified by a reputed CRO in Poland, and samples have been shared with prospective customers.
• No forward number on the mix: When an analyst asked whether biologicals could reach 15-20% of revenue in 2-3 years, management declined to commit, saying only "it will be quite good, it will be promising."

Exports & Geopolitical Drag

• Multiple conflict zones weighing on shipments: Instability in Ethiopia, Red Sea disruption, and ongoing conflicts in Iran and Ukraine kept exports challenged through Q2.
• Registration progress offers a near-term catalyst: One or two products are expecting export registrations that could convert in Q3 or Q4, providing a potential incremental lift.

Capex, Costs & Balance Sheet

• Barwasni expansion on track: The IPO-funded capex of ₹14 crores saw minimal utilisation in Q2 as focus stayed on seasonal sales. Full-scale deployment begins in Q3, with completion expected over the next two quarters and commissioning from the end of this fiscal year. The new DF facility is part of this plan.
• Term loan repaid: IPO proceeds have been used to retire the term loan; only working capital loans remain on the books. Management hopes interest costs will reduce further by March.
• EBITDA surged 70% YoY in Q2: The jump was driven by enhanced operational efficiency and leverage optimisation, even on a depressed revenue base. Q3 EBITDA margin is expected to improve on last Q3's ~10%.

Guidance & Commitments

Key Metrics